These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14204592)

  • 1. [APROPOS OF AUTO-ANTIBODY FORMATION IN LUPUS ERYTHEMATOSUS].
    STAEPS R
    Dtsch Gesundheitsw; 1964 Apr; 19():797-803. PubMed ID: 14204592
    [No Abstract]   [Full Text] [Related]  

  • 2. Auto-immunity and systemic lupus erythematosus.
    Whaley K
    Med Lab Technol; 1972 Apr; 29(2):133-42. PubMed ID: 4116076
    [No Abstract]   [Full Text] [Related]  

  • 3. [EXPERIMENTAL PATHOGENETIC STUDIES WITH THE FLUORESCENT ANTIBODY TECHNIC IN LUPUS ERYTHEMATOSUS. APROPOS OF THE UNITARY PATHOGENESIS OF ACUTE AND CHRONIC LUPUS ERYTHEMATOSUS].
    MENEGHINI CL; COZZA G
    G Ital Dermatol; 1964; 105():45-52. PubMed ID: 14135368
    [No Abstract]   [Full Text] [Related]  

  • 4. [IMMUNOHEMATOLOGIC CHANGES IN DISSEMINATED LUPUS ERYTHEMATOSUS].
    SHOPOV PV
    Klin Med (Mosk); 1965 Jan; 43():48-53. PubMed ID: 14344795
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON THE ANTINUCLEAR FACTOR IN COLLAGEN DISEASES, WITH SPECIAL REFERENCE TO ACUTE LUPUS ERYTHEMATOSUS].
    MINAMI K; KODA H; TOGEGAWA S
    Fukuoka Igaku Zasshi; 1964 Mar; 55():167-73. PubMed ID: 14165106
    [No Abstract]   [Full Text] [Related]  

  • 6. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
    Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
    Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIGNIFICANCE OF ANTIBODY TO DNA IN SYSTEMIC LUPUS ERYTHEMATOSUS.
    CASALS SP; FRIOU GJ; MYERS LL
    Arthritis Rheum; 1964 Aug; 7():379-90. PubMed ID: 14202576
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of results of studies of the LE phenomenon and immunofluorescent studies in 100 patients with visceral lupus erythematosus].
    Kardaszewicz E
    Pol Tyg Lek; 1971 Mar; 26(9):297-300. PubMed ID: 4101394
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lysosomal apparatus of the reticuloendothelial system cells and the pathogenesis of systemic lupus erythematosus].
    Volkova ZI; Kaĭnova AS
    Vopr Revm; 1980; (3):55-8. PubMed ID: 6158792
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison between FA factor and LE cell tests.
    Peterson WC; Haserick JR
    Arch Dermatol; 1966 Nov; 94(5):609-12. PubMed ID: 4163798
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic lupus erythematosus.
    Bitter T
    Rheumatology; 1974; 5(0):49-243. PubMed ID: 4137228
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic lupus erythematosus: antinuclear serology and cell-mediated immunity in the light of clinico-hematologic diagnostic criteria. Preliminary communication.
    Bitter T
    Schweiz Med Wochenschr; 1971 Feb; 101(6):181-6. PubMed ID: 4104947
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and pathogenic significance of vascular autoantibodies in systemic lupus erythematosus].
    Mitu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(3):251-6. PubMed ID: 6138838
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunopathologic studies of systemic lupus erythematosus (SLE). I. Tissue-bound immunoglobulins in relation to serum antinuclear immunoglobulins in systemic lupus and in chronic liver disease with LE cell factor.
    Svec KH; Blair JD; Kaplan MH
    J Clin Invest; 1967 Apr; 46(4):558-68. PubMed ID: 4164259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The primary chronic polyarthritis with LE cells, a link to systemic lupus erythematosus].
    Geidel H
    Munch Med Wochenschr; 1967 Dec; 109(48):2534-9. PubMed ID: 4174576
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CANINE SYSTEMIC LUPUS ERYTHEMATOSUS.
    LEWIS RM; SCHWARTZ R; HENRY WB
    Blood; 1965 Feb; 25():143-60. PubMed ID: 14267691
    [No Abstract]   [Full Text] [Related]  

  • 18. The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus.
    Rensch MJ; Szyjkowski R; Shaffer RT; Fink S; Kopecky C; Grissmer L; Enzenhauer R; Kadakia S
    Am J Gastroenterol; 2001 Apr; 96(4):1113-5. PubMed ID: 11316156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PRODUCTION OF ANTINUCLEAR ANTIBODIES IN ANIMAL EXPERIMENTS. STUDIES ON THE IMMUNOLOGY OF VISCERAL LUPUS ERYTHEMATOSUS].
    HEIDE G; DEICHER H; HARTMANN F
    Dtsch Arch Klin Med; 1963 Dec; 209():144-65. PubMed ID: 14126762
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematosus and their clinical relevance. I. DNA-binding autoantibodies].
    Wollina U
    Allerg Immunol (Leipz); 1983; 29(3):127-34. PubMed ID: 6227213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.